SCHEMBL5835115

SCHEMBL5835115

CCCCCCOC(=O)N(C(=O)Nc1ccc(N(CC)CC)cc1)C1CCc2ccccc2C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 3/20 0.53
NPY5R Q15761 2/20 0.47
NAMPT P43490 1/20 0.39
TAOK3 Q9H2K8 2/20 0.39
RAB9A P51151 3/20 0.38
NPC1 O15118 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NOX1 Q9Y5S8 1/20 0.38
HTR1A P08908 1/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
MCL1 Q07820 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MCHR1 Q99705 1/20 0.37
TAOK1 Q7L7X3 1/20 0.37
GCGR P47871 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835266 0.99 GHSR (0.54) GHSRNPY5RNAMPTTAOK3RAB9A
SCHEMBL5835198 0.96 GHSR (0.55) GHSRNPY5RTAOK3RAB9ANPC1
SCHEMBL5835382 0.93 GHSR (0.57) GHSRNPY5RRAB9ANPC1MEN1
SCHEMBL5834913 0.91 GHSR (0.53) GHSRNPY5RRAB9ANPC1MEN1
SCHEMBL5835311 0.89 GHSR (0.55) GHSRNPY5RRAB9ANPC1MEN1
SCHEMBL5834802 0.89 GHSR (0.59) GHSRNPY5RRAB9ANPC1MEN1
SCHEMBL5834823 0.87 GHSR (0.56) GHSRNPY5RRAB9ANPC1MEN1
SCHEMBL5834803 0.86 GHSR (0.52) GHSRNPY5RRAB9ANPC1MEN1
SCHEMBL5835145 0.85 GHSR (0.55) GHSRNPY5RRAB9ANPC1MEN1
SCHEMBL5834787 0.85 GHSR (0.55) GHSRNPY5RRAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US claimed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US claimed
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR GHSR 2/4885NPY5R 43/4885NAMPT 1730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.